Topic Applera

News Applera

• Applied Biosystems, 454 Life Sciences and Illumina Join 1000 Genomes Project

  Leaders of the 1000 Genomes Project announced that three firms that have pioneered development of new sequencing technologies have joined the international effort to build the most detailed map to date of human genetic variation as a tool for medical research. The new participants are: Applied Biosy more

• BIOTECON Diagnostics signs license agreement with Applera Corporation

  Applera and BIOTECON Diagnostics (BCD) announced a non-exclusive, worldwide license agreement relating to PCR technology for Food Testing Applications and Genetically-Modified Organism (GMO) Testing Applications: BIOTECON Diagnostics has acquired important rights with the PCR licence. In the futur more

• Lab21 signs a license with Celera for one of the first diagnostic tests for cirrhosis risk in hepatitis C patients

  Lab21 announced that it has obtained a licence from Celera, an Applera Corporation business, to provide access to its test for cirrhosis risk in patients with chronic hepatitis C viral (HCV) infection in the UK and Ireland. The test, known as CRS7, is the first clinical test capable of predicting t more